BioHarvest Sciences Inc. Common Stock
BHST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $100 | $68 | $65 | $62 |
| - Cash | $2 | $5 | $2 | $4 |
| + Debt | $14 | $22 | $11 | $3 |
| Enterprise Value | $112 | $85 | $74 | $61 |
| Revenue | $25 | $13 | $5 | $2 |
| % Growth | 98.8% | 130.5% | 161.6% | – |
| Gross Profit | $14 | $6 | $1 | $1 |
| % Margin | 55.4% | 44.5% | 22.2% | 31.9% |
| EBITDA | -$10 | -$10 | -$9 | -$9 |
| % Margin | -38.6% | -77% | -166% | -410.9% |
| Net Income | -$13 | -$13 | -$11 | -$10 |
| % Margin | -51.3% | -99.1% | -204.4% | -467.5% |
| EPS Diluted | -0.8 | -0.93 | -0.7 | -0.7 |
| % Growth | 14% | -32.9% | 0% | – |
| Operating Cash Flow | -$7 | -$9 | -$9 | -$7 |
| Capital Expenditures | -$3 | -$1 | -$1 | -$2 |
| Free Cash Flow | -$10 | -$10 | -$10 | -$8 |